Single-Dose Tolerability, Pharmacokinetics, and Pharmacodynamics of Etamicastat (BIA 5-453), a New Dopamine β-Hydroxylase Inhibitor, in Healthy Subjects-Reference-Cited by-同舟云学术

Single-Dose Tolerability, Pharmacokinetics, and Pharmacodynamics of Etamicastat (BIA 5-453), a New Dopamine β-Hydroxylase Inhibitor, in Healthy Subjects

Published:2012-02 Issue:2 Volume:52 Page:156-170
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Rocha José Francisco,Vaz-Da-Silva Manuel,Nunes Teresa,Igreja Bruno,Loureiro Ana I.,Bonifácio Maria João,Wright Lyndon C.,Falcão Amílcar,Almeida Luis,Soares-Da-Silva Patricio

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270010390805/fullpdf

Reference31 articles.

1. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease;Esler;J Cardiovasc Pharmacol,2000

2. Sympathetic activation in congestive heart failure: reproducibility of neuroadrenergic markers;Grassi;Eur J Heart Fail,2008

3. The “neuroadrenergic hypothesis” in hypertension: current evidence;Grassi;Exp Physiol,2010

4. Current concepts of neurohormonal activation in heart failure: mediators and mechanisms;Lee;AACN Adv Crit Care,2008

5. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage;Mancia;Hypertension,1999

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, conduct, and interpretation of human mass balance studies and strategies for assessing metabolites-in-safety testing (MIST) in drug development;Overcoming Obstacles in Drug Discovery and Development;2023

2. Therapeutic enzymes as non-conventional targets in cardiovascular impairments: A comprehensive review;Canadian Journal of Physiology and Pharmacology;2021-12-21

3. Case Study 10: A Case to Investigate Acetyl Transferase Kinetics;Methods in Molecular Biology;2021

4. Dopamine β hydroxylase as a potential drug target to combat hypertension;Expert Opinion on Investigational Drugs;2020-08-04

5. Dopamine Beta Hydroxylase: An Enzyme with Therapeutic Potential to Combat Neural and Cardiovascular Diseases;Frontiers in Protein Structure, Function, and Dynamics;2020